Pazenir
Analogs of Pazenir
Find cheaper analogs and generic equivalents for Pazenir.
Active Ingredient: paclitaxel
Product Overview
About Pazenir
Pazenir is a cancer medicine.
What it is used for
Pazenir is used to treat metastatic breast cancer, metastatic adenocarcinoma of the pancreas, and non-small cell lung cancer.
How it is used
Pazenir is given as an infusion into a vein over a period of 30 minutes. The recommended dose depends on the patient’s height and weight.
In metastatic breast cancer, Pazenir is given on its own every three weeks.
In metastatic adenocarcinoma of the pancreas, Pazenir is given in 4-week treatment cycles. The medicine is given once a day on days 1, 8 and 15 of each cycle.
Immediately after giving Pazenir, gemcitabine should be given.
In non-small cell lung cancer, treatment is carried out in 3-week cycles with Pazenir given on days 1, 8 and 15 of each cycle and carboplatin given on day 1 immediately after Pazenir.
Pazenir should only be given under the supervision of a cancer doctor in clinics that are specialised in giving ‘cytotoxic’ (cell-killing) medicines.
It should not be interchanged with other medicines containing paclitaxel.
The medicine can only be obtained with a prescription.
How it works
The active substance in Pazenir, paclitaxel, belongs to the group of cancer medicines known as the ‘taxanes’.
Paclitaxel blocks a stage of cell division in which the cell’s internal ‘skeleton’ is dismantled to allow the cell to divide.
By keeping this structure intact, the cells cannot divide and they eventually die.
Pazenir also affects non-cancer cells such as blood and nerve cells, which can cause side effects.
Active substance: paclitaxel
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
